Boiron SA
PAR:BOI

Watchlist Manager
Boiron SA Logo
Boiron SA
PAR:BOI
Watchlist
Price: 28.1 EUR -4.75% Market Closed
Market Cap: 487.9m EUR
Have any thoughts about
Boiron SA?
Write Note

Operating Margin
Boiron SA

6.1%
Current
10%
Average
6.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
6.1%
=
Operating Profit
29.4m
/
Revenue
481.7m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
FR
Boiron SA
PAR:BOI
487.9m EUR
6%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-83%
US
Eli Lilly and Co
NYSE:LLY
710.5B USD
35%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK
44%
US
Johnson & Johnson
NYSE:JNJ
373.5B USD
28%
US
Merck & Co Inc
NYSE:MRK
251.1B USD
34%
CH
Roche Holding AG
SIX:ROG
202.7B CHF
32%
CH
Novartis AG
SIX:NOVN
183.3B CHF
31%
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP
21%
IE
Endo International PLC
LSE:0Y5F
146B USD
11%
Country FR
Market Cap 487.9m EUR
Operating Margin
6%
Country JP
Market Cap 776 550.9T JPY
Operating Margin
-83%
Country US
Market Cap 710.5B USD
Operating Margin
35%
Country UK
Market Cap 440.4B GBP
Operating Margin
3%
Country DK
Market Cap 3.3T DKK
Operating Margin
44%
Country US
Market Cap 373.5B USD
Operating Margin
28%
Country US
Market Cap 251.1B USD
Operating Margin
34%
Country CH
Market Cap 202.7B CHF
Operating Margin
32%
Country CH
Market Cap 183.3B CHF
Operating Margin
31%
Country UK
Market Cap 162.4B GBP
Operating Margin
21%
Country IE
Market Cap 146B USD
Operating Margin
11%
No Stocks Found

Boiron SA
Glance View

Market Cap
487.9m EUR
Industry
Pharmaceuticals

Boiron SA engages in the manufacturing and selling homeopathic medicines. The company is headquartered in Rontalon, Auvergne-Rhone-Alpes. The firm develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. The company also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.

BOI Intrinsic Value
39.68 EUR
Undervaluation 29%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
6.1%
=
Operating Profit
29.4m
/
Revenue
481.7m
What is the Operating Margin of Boiron SA?

Based on Boiron SA's most recent financial statements, the company has Operating Margin of 6.1%.